SCHEMBL9008328

SCHEMBL9008328

c1ccc2c(c1)CC(c1ccc3ccccc3n1)[N]2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.41
RAB9A P51151 6/20 0.41
ALDH1A1 P00352 5/20 0.41
CYP3A4 P08684 4/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 3/20 0.41
MAPK1 P28482 1/20 0.41
HIF1A Q16665 1/20 0.41
CYP1A2 P05177 4/20 0.35
NCF1 P14598 2/20 0.35
NOS2 P35228 1/20 0.35
BACE1 P56817 1/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
HRH3 Q9Y5N1 3/20 0.35
KDM4E B2RXH2 5/20 0.34
AR P10275 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370064 0.84 NPC1 (0.40) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL7037068 0.74 ALDH1A1 (0.47) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL28995850 0.69 ADRA1A (0.49) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL12533917 0.67 ALDH1A1 (0.52) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL12533914 0.67 ALDH1A1 (0.52) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL12533920 0.67 ALDH1A1 (0.52) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL902873 0.67 NPC1 (0.52) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL29390450 0.67 NPC1 (0.52) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL2808040 0.67 ALDH1A1 (0.38) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL9847248 0.66 AOC3 (0.36) NPC1RAB9AALDH1A1MAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5491152-A Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-02-13 US disclosed